Royce & Associates LP Avid Bioservices, Inc. Transaction History

Royce & Associates LP

$10.5 Billion
Q3 2024

A detailed history of Royce & Associates LP transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 789,227 shares of CDMO stock, worth $9.68 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

789,227

Previous 732,116 7.8%

Holding current value

$9.68 Million

Previous $5.23 Million 71.82%

% of portfolio

0.09%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$6.7 - $12.45 $382,643 - $711,031	57,111 Added 7.8%	789,227 $8.98 Million
Q2 2024 Aug 13, 2024	BUY	$6.34 - $9.28 $594,793 - $870,612	93,816 Added 14.7%	732,116 $5.23 Million
Q1 2024 May 13, 2024	BUY	$5.86 - $8.79 $821,747 - $1.23 Million	140,230 Added 28.15%	638,300 $4.28 Million
Q4 2023 Feb 12, 2024	BUY	$4.64 - $9.56 $1.02 Million - $2.1 Million	220,070 Added 79.16%	498,070 $3.24 Million
Q3 2023 Nov 09, 2023	SELL	$9.4 - $14.04 $235,000 - $351,000	-25,000 Reduced 8.25%	278,000 $2.62 Million
Q1 2023 May 04, 2023	BUY	$13.48 - $18.79 $633,560 - $883,130	47,000 Added 18.36%	303,000 $5.68 Million
Q4 2022 May 23, 2023	SELL	$12.61 - $18.74 $592,670 - $880,779	-47,000 Reduced 15.51%	256,000 $3.53 Million
Q4 2022 Feb 13, 2023	BUY	$12.61 - $18.74 $524,576 - $779,583	41,600 Added 19.4%	256,000 $3.53 Million
Q3 2022 Nov 03, 2022	SELL	$15.33 - $20.36 $1.77 Million - $2.35 Million	-115,300 Reduced 34.97%	214,400 $4.1 Million
Q2 2022 Aug 04, 2022	SELL	$11.63 - $21.55 $564,055 - $1.05 Million	-48,500 Reduced 12.82%	329,700 $5.03 Million
Q1 2022 May 05, 2022	BUY	$16.63 - $27.73 $3.15 Million - $5.25 Million	189,500 Added 100.42%	378,200 $7.7 Million
Q4 2021 Feb 07, 2022	SELL	$20.7 - $34.18 $805,230 - $1.33 Million	-38,900 Reduced 17.09%	188,700 $5.51 Million
Q3 2021 Nov 10, 2021	SELL	$19.05 - $28.32 $64,770 - $96,288	-3,400 Reduced 1.47%	227,600 $4.91 Million
Q2 2021 Aug 06, 2021	SELL	$18.93 - $25.65 $836,706 - $1.13 Million	-44,200 Reduced 16.06%	231,000 $5.93 Million
Q1 2021 May 10, 2021	SELL	$11.86 - $21.77 $39,138 - $71,841	-3,300 Reduced 1.18%	275,200 $5.02 Million
Q4 2020 Feb 08, 2021	BUY	$7.25 - $11.76 $155,875 - $252,840	21,500 Added 8.37%	278,500 $3.21 Million
Q2 2020 Aug 07, 2020	SELL	$4.11 - $6.78 $172,620 - $284,760	-42,000 Reduced 14.05%	257,000 $1.69 Million
Q1 2020 May 12, 2020	SELL	$3.15 - $7.39 $110,250 - $258,650	-35,000 Reduced 10.48%	299,000 $1.53 Million
Q3 2019 Nov 13, 2019	BUY	$5.07 - $7.08 $172,380 - $240,720	34,000 Added 11.33%	334,000 $1.77 Million
Q2 2019 Aug 12, 2019	BUY	$3.43 - $5.6 $1.03 Million - $1.68 Million	300,000 New	300,000 $1.68 Million

Others Institutions Holding CDMO

# of Institutions

183

Shares Held

67.8M

Call Options Held

89.9K

Put Options Held

118K

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $763M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Avid Bioservices, Inc. Transaction History